Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis

International Immunopharmacology 2026

View at publisher
Authors: Xiangxiang Huang, Lei Zhang, Nuo Chen, Binquan Huang, Yan Zhao, Chenggong Zhu, Shuliang Zhang, Jiarui Xia, LINGZHOU ZHANG, Lei Liu, Xiaoyong Lin
DOI: 10.1016/j.intimp.2026.116565
Cited by: 2
References: 50

Fields of Study & Subjects

Osteoarthritis Treatment and Mechanisms Inflammasome and immune disorders Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
179
Pages
116565–116565
Publication date
4 April 2026
Language
EN